Digital technologies in mental health care, advanced therapies for rare diseases, and improving hospital care are among the topics pencilled in for IHI’s next calls for proposals.
The Innovative Health Initiative (IHI) has published the preliminary topics for the next calls, in order to allow those interested in participating to prepare in advance for the construction of the partnership.
As regards IHI Call 3, scheduled to start at the end of 2022 and of the single-stage type, the relevant topics are:
- Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
- Topic 2: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
- Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
- Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases
- Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences
The topics of call 4, scheduled for the beginning of 2023 and divided into two phases, are:
- Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment
- Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare
Currently, the draft topics are under consultation with IHI’s States Representatives Group and Science and Innovation Panel. It is therefore likely that the topics may change considerably between now and the call launch, and applicants should check the final, approved topic texts once the calls are launched.
The IHI Programme Office is planning webinars and a brokerage opportunities around the time of the call launches to help applicants learn more about the topics as well as IHI’s rules and procedures.
Written by Giuditta Pasta – ValueDo (Florence, Italy)